Purinethol®

INN: mercaptopurine

Approved for use in:

Crohn’s Disease (moderate-severe)
Ulcerative Colitis (moderate-severe)

Type/Class

Immunomodulator

Delivery Route

Oral (tablet)

Health Canada Approval

2003

Storage

Store between 15 and 25°C, protect from light, do not take after expiry date.

Use in Older Adults (65+)

May be used; monitor hepatic and renal function.

Pregnancy Indication

Can cause fetal harm; avoid when possible.

Breastfeeding Indication

Not recommended.

Pediatric Indication

Authorized.

Learn More

View the Purinethol® product monograph.